Detalles de la búsqueda
1.
TGFß attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Nature
; 554(7693): 544-548, 2018 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29443960
2.
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Lancet
; 393(10189): 2404-2415, 2019 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-31079938
3.
Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial.
Lancet
; 391(10122): 748-757, 2018 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29268948
4.
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.
Lancet Oncol
; 18(6): 732-742, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28526536
5.
Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population.
Cancer Causes Control
; 27(9): 1127-38, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27496200
6.
Contrast-Enhanced Computed Tomography Evaluation of Hepatic Metastases in Breast Cancer Patients Before and After Cytotoxic Chemotherapy or Targeted Therapy.
Can Assoc Radiol J
; 66(4): 356-62, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26165625
7.
Pilot study to assess toxicity and pharmacokinetics of docetaxel in patients with metastatic breast cancer and impaired liver function secondary to hepatic metastases.
J Oncol Pharm Pract
; 20(2): 120-9, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23676510
8.
Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer.
J Clin Oncol
; 41(10): 1809-1815, 2023 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36989609
9.
Molecular Subsets in Renal Cancer Determine Outcome to Checkpoint and Angiogenesis Blockade.
Cancer Cell
; 38(6): 803-817.e4, 2020 12 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33157048
10.
Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials.
Clin Cancer Res
; 13(16): 4943-8, 2007 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17699874
11.
Neoadjuvant therapy with paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide chemotherapy and concurrent trastuzumab in human epidermal growth factor receptor 2-positive operable breast cancer: an update of the initial randomized study population and data of additional patients treated with the same regimen.
Clin Cancer Res
; 13(1): 228-33, 2007 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17200359
12.
Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks.
J Clin Oncol
; 23(25): 5983-92, 2005 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16087943
13.
Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer.
J Clin Oncol
; 23(16): 3676-85, 2005 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15738535
14.
Neoadjuvant chemotherapy for operable breast cancer.
Oncology (Williston Park)
; 16(7): 871-84, 889; discussion 889-90, 892-4, 897-8, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12164555
15.
Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor-positive metastatic breast cancer.
Cancer Chemother Pharmacol
; 71(1): 63-72, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23053261
16.
Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy.
Radiat Oncol
; 8: 13, 2013 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23311297
17.
Short-term biomarker modulation prevention study of anastrozole in women at increased risk for second primary breast cancer.
Cancer Prev Res (Phila)
; 5(2): 276-82, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22102688
18.
Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.
Surgery
; 151(5): 710-6, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22285778
19.
Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.
J Clin Oncol
; 30(9): 930-5, 2012 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22331946
20.
Phase II trial of anastrozole plus goserelin in the treatment of hormone receptor-positive, metastatic carcinoma of the breast in premenopausal women.
J Clin Oncol
; 28(25): 3917-21, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20679610